1. Home
  2. WAY vs CRL Comparison

WAY vs CRL Comparison

Compare WAY & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waystar Holding Corp. Common Stock

WAY

Waystar Holding Corp. Common Stock

HOLD

Current Price

$34.37

Market Cap

6.7B

Sector

N/A

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$184.50

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAY
CRL
Founded
1999
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
8.0B
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
WAY
CRL
Price
$34.37
$184.50
Analyst Decision
Strong Buy
Buy
Analyst Count
14
15
Target Price
$47.86
$190.15
AVG Volume (30 Days)
1.6M
940.7K
Earning Date
10-29-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$1,039,842,000.00
$4,023,704,000.00
Revenue This Year
$15.31
N/A
Revenue Next Year
$16.18
$1.66
P/E Ratio
$55.23
N/A
Revenue Growth
14.76
N/A
52 Week Low
$29.78
$91.86
52 Week High
$48.11
$202.72

Technical Indicators

Market Signals
Indicator
WAY
CRL
Relative Strength Index (RSI) 38.45 62.56
Support Level $34.48 $176.37
Resistance Level $35.64 $186.72
Average True Range (ATR) 1.22 5.89
MACD -0.08 1.82
Stochastic Oscillator 13.84 92.60

Price Performance

Historical Comparison
WAY
CRL

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: